UPMC makes $200M investment in immunotherapy hub: 3 things to know

Morgan Haefner - Print  | 

Pittsburgh-based UPMC, in partnership with the University of Pittsburgh, will build an eight-story immune transplant center in Pittsburgh.

Here are three things to know about the project.

1. The UPMC Immune Transplant and Therapy Center will initially focus on transplantation, cancer, and aging and chronic diseases.

2. UPMC made a $200 million, three-year funding commitment to ITTC. The investment aims to "dramatically accelerate the pace at which medical teams can utilize new research," UPMC said.

3. ITTC will feature lab and office space, as well as space for startup firms and industry partners.

More articles on finance:
Trump's 2019 budget blueprint: 15 healthcare takeaways
What the Amazon, JPMorgan, Berkshire partnership means for healthcare: 35 executives respond
OIG tags Michigan health system for erroneous billing

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.